Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ID: DRG0HVXED)
| ADC Name |
ORM-5029
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
ORM-5029
Click to Show/Hide
|
|||||
| Organization |
Orum Therapeutics (Originator)
|
|||||
| Drug Status |
Phase 1 (discontinued)
|
|||||
| Drug-to-Antibody Ratio |
4
|
|||||
| Structure |
|
|||||
|
|
||||||
| Antibody Name |
Pertuzumab
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (HER2)
|
Antigen Info | ||||
| Payload Name |
SMol006
|
Payload Info | ||||
| Payload Target |
CRBN×GSPT1
|
Target Info | ||||
| Linker Name |
Mc-Val-Cit-PABC
|
Linker Info | ||||
| Conjugate Type |
Random Cysteines
|
|||||
2027 Update
The disease landscape of This ADC
2027 Update
The clinical trial pipelines of This ADC